Product Program year 2025 Source: CMS Open Payments

Stimrouter Implantable Kit

Device Podiatry

PDI 00815962020016

Open in the dashboard

General payments

$653,098

2,461 payments

Research payments

$257,992

35 payments

Through program year 2025, $653,098 in general payments and $257,992 in research payments were reported against Stimrouter Implantable Kit (Podiatry).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $124,927 279
2024 General $87,047 200
2024 Research $25,561 2
2023 General $281,461 842
2023 Research $152,744 17
2022 General $152,506 995
2022 Research $79,687 16
2021 General $7,157 145

Breakdown

Who paid General payments · program years 2021–2025
  1. Bioventus LLC $653,098 2,461 payments
Top recipients General payments · program year 2025
  1. David Spinner Pain Medicine · New York, NY $35,067 28% · 24 payments
  2. Vinod Dasa Orthopaedic Surgery · Kenner, LA $30,424 24% · 26 payments
  3. Alexandra Adler Pain Medicine · Lowell, MA $8,163 7% · 8 payments
  4. Stephen Barrett Podiatrist · Marietta, GA $8,054 6% · 10 payments
  5. Hemant Kalia Interventional Pain Medicine · Rochester, NY $7,940 6% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pain Medicine Physical Medicine & Rehabilitation $37,381 30% · 7 practitioners
  2. Orthopaedic Surgery $35,941 29% · 10 practitioners
  3. Pain Medicine Anesthesiology $16,924 14% · 14 practitioners
  4. Interventional Pain Medicine Pain Medicine $9,735 8% · 13 practitioners
  5. Podiatrist $8,326 7% · 6 practitioners

The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $44,399 36% · 9 recipients
  2. Louisiana $30,630 25% · 8 recipients
  3. Massachusetts $11,781 9% · 4 recipients
  4. North Carolina $9,285 7% · 8 recipients
  5. Georgia $8,054 6% · 1 recipient

The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,461 general · 35 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record